Our products
PharmaInformatic´s expert systems help to identify and prioritise promising drug candidates with the maximum possibility of success in human trials. MolScore-products preselect compounds which display a high probability of becoming a successful drug:
Our
expert systems
are based on novel models and innovative methods in the field of drug design.
We use proprietary molecular descriptors and a huge amount of data and knowledge from literature to find relationships between molecular structures and biological activity.
The knowledge of our expert systems is used by our clients to filter large compound libraries.
Expert system to identify and prioritise
suitable drug candidates
Application of customised tools derived from our ADME/Tox database improve the identification of potential risks in order to reduce clinical failures.
MolScore-products can be combined with other predictive tools to select the most suitable drug candidates for further development, see lead selection & prioritisation.
Buying compounds from external suppliers is expensive, and only a small amount of these substances come up to expectations. Use PharmaInformatic´s expert systems to find the right compounds which fit into your specific drug development programme. By using MolScore-products the screening becomes more effective and customers will substantially reduce their drug development costs and time.
Expert system to identify and prioritise
suitable antiviral drug candidates
Expert system to identify and prioritise
suitable antibacterial drug candidates
 |
 |
 |
 |
 |
|
|
|
© Copyright 2004-2008 PharmaInformatic Boomgaarden. All rights reserved. Site map Contact Terms of Use Imprint |
Our proprietary
platform technology
contains tens of millions of substances together with experimental data,
tens of thousands of 3D- models and
a huge amount of related scientific data.
The number of potential molecules in pharmaceutical in-house databases has increased to such an extent, that the screening of all substances for possible drug applications has become ineffective and highly
cost-sensitive.